Gestational hypertension is classified as a new onset of high blood pressure developing after 20 weeks of gestation in a previously normotensive woman. Specifically, it is diagnosed when the systolic reading reaches 140 mmHg or higher, or the diastolic reading hits 90 mmHg or higher, measured on at least two separate occasions at least four hours apart. Proteinuria must be absent for the diagnosis to remain strictly gestational hypertension; if protein appears in the urine alongside the elevated blood pressure, the condition is reclassified as preeclampsia. Midwives in Nigerian clinical settings must ensure that blood pressure is taken using an appropriately sized cuff while the woman is seated or lying in a semi-recumbent position after a period of rest, avoiding false readings caused by anxiety or physical exertion.
The exact root cause of gestational hypertension remains complex, involving abnormal placental development and maternal vascular endothelial dysfunction. Unlike chronic hypertension that exists before pregnancy, gestational hypertension stems from inadequate trophoblast invasion of the maternal spiral arteries. This leaves the uteroplacental vessels narrowed and poorly compliant, creating high resistance and reduced blood flow to the developing fetus. The stressed placenta then releases inflammatory factors into the maternal circulation, causing widespread constriction of maternal blood vessels. This systemic vasoconstriction leads directly to the elevated blood pressure readings observed during routine antenatal visits.
Regular monitoring of pregnant women allows midwives to detect subtle shifts in maternal wellness before severe complications take hold. While gestational hypertension can sometimes present with no noticeable symptoms, women must be actively screened for red-flag complaints during every antenatal visit.
Once gestational hypertension is identified, rigorous surveillance safeguards both mother and baby. Baseline laboratory investigations are essential to evaluate organ function, including complete blood counts, liver enzymes, serum creatinine, and urinalysis for protein. Fetal well-being is assessed through serial growth scans, amniotic fluid volume checks, and biophysical profiles or cardiotocography. Midwives must track blood pressure trends closely, educating women on home monitoring where resources permit, while establishing clear low-threshold criteria for immediate hospital referral if danger signs emerge.
Care plans for women with gestational hypertension depend heavily on gestational age and the presence of maternal symptoms. If blood pressure remains mildly elevated without complications near term, induction of labor around 37 to 38 weeks is often recommended to prevent progression. For preterm diagnoses, expectant management involving close inpatient or outpatient surveillance is favored to allow further fetal maturation. Midwives play a crucial role in promoting rest, monitoring fluid balance, administering prescribed antihypertensive medications such as methyldopa or labetalol, and offering psychological reassurance to an anxious mother and her family.
Gestational hypertension is an unstable condition that can transition into preeclampsia at any point. Midwives must remain vigilant for red flags that signal this dangerous shift. The emergence of persistent proteinuria is the classic diagnostic turning point, but the onset of severe headache, visual disturbances, or upper abdominal pain also signals deterioration even before protein tests return. Laboratory markers such as a rising serum creatinine, elevated liver enzymes, or a dropping platelet count confirm multi-organ involvement. Recognizing these warning signs promptly ensures timely administration of magnesium sulfate for seizure prophylaxis and prevents catastrophic maternal outcomes like eclampsia or stroke.